|Title:||SEA/RC67/29 - Viral hepatitis|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||Viral hepatitis is a serious public health problem worldwide, as well as for the South-East Asia Region. Hepatitis B and C account for a greater health burden and a higher mortality rate because they can cause chronic infection, which, in turn, can lead to hepatic cirrhosis and cancer. Approximately 1.4 million deaths are caused every year worldwide by hepatitis viruses. Of these, an estimated 800 000 are due to hepatitis B and about 500 000 due to hepatitis C infection. Around 500 000 estimated deaths in the WHO South-East Asia Region occur due to hepatitis viruses. The regional strategy for the prevention and control of viral hepatitis (SEA-CD-282) published in 2013 has six strategic pillars: a) policy, planning and resource mobilization; b) surveillance; c) research; d) prevention and control; e) education; and f) medical care and treatment. The regional strategy can be considered for adoption by Member States in their own context and in alignment with their needs and health system requirements. The High-Level Preparatory (HLP) Meeting held in the Regional Office in New Delhi from 14 to 17 July 2014 reviewed the attached working paper and made the following recommendations: Action by Member States (1) Member States may consider launching a coordinated, collaborative and sustained approach for viral hepatitis prevention, education, surveillance, medical care and treatment, research, policy, planning and resource mobilization and may wish to align it with the Regional Strategy on Prevention and Control of Viral Hepatitis (2013). Actions by the WHO Regional Office (1) Technical assistance may be provided, on request, to Member States in developing national plans in the context of local epidemiology. (2) Member States should be assisted in strengthening diagnostic laboratories and laboratory-based surveillance for accurate estimation of disease burden as well as ensuring rational case management. (3) The subject of viral hepatitis may be included in the agenda of the Sixty-seventh Session of the Regional Committee at Dhaka in September 2014. The working paper and the HLP recommendations are submitted to the Sixty-seventh Session of the Regional Committee for its consideration.|
|Gov't Doc #:||SEA/RC67/29|
|Appears in Collections:||Regional Committee Meeting 67 Dhaka, Bangladesh, 10-12 September 2014|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.